As the medical community swiftly embraces thyroid ablation, a groundbreaking non-surgical treatment for thyroid nodules, concerns arise about the potential risks associated with its rapid adoption. Key among these concerns is the lack of ultrasound expertise among practitioners and the contentious decision to treat nodules that may be too small to warrant intervention. This article delves into the insights of Dr. Jagdish Dhingra, a seasoned thyroid surgeon, who highlights the crucial balance between leveraging medical innovations and ensuring patient safety through skilled application and judicious treatment decisions.

In the rapidly evolving field of medical treatments, thyroid ablation stands out as a significant advancement, offering a non-surgical option for patients with thyroid nodules. However, the quick adoption of this technique across the United States has raised concerns among experts about its application and the potential risks involved. In a recent interview on the RFAMD podcast, hosted by Philip James, Dr. Jagdish Dhingra, a seasoned thyroid surgeon with over 25 years of experience, shared his insights on the dangers of the rapid embrace of thyroid ablation and the critical importance of skilled ultrasound technique in its success.

Goodwill missions to Africa

Dr. Dhingra, known for his extensive work and goodwill missions in Africa, particularly Rwanda, where he volunteers to perform surgeries on women affected by large goiters, emphasizes the need for caution. His annual trips to Africa highlight his commitment to addressing thyroid-related conditions and his expertise in managing complex cases.

  Goiter in Colombia

The conversation also touched upon the impressive work of Dr. Juan Pablo Dueñas in Medellín, Colombia, who successfully treated a patient with a very large goiter using ablation. This case exemplifies the potential of thyroid ablation when applied correctly and with the requisite skill.

Dangers of thyroid ablation and ultrasound

However, Dr. Dhingra pointed out the significant risks associated with the procedure, especially when used for nodules that are too small or by practitioners lacking in precise ultrasound-guided techniques. He warned against the treatment of small, benign thyroid nodules with ablation, arguing that observation rather than intervention is often the best approach in such cases. The risks, including major vessel and nerve injury, are heightened in the absence of expertise in ultrasound guidance.

The expertise required for safe and effective thyroid ablation extends beyond surgical skills, involving proficiency in ultrasound to avoid damaging vital neck structures. This underscores the importance of comprehensive training and experience in both ultrasound and surgery for those performing thyroid ablations.

Thyroid ablation guidelines

As thyroid ablation gains popularity, Dr. Dhingra advocates for establishing and adhering to strict guidelines to ensure patient safety. These guidelines would ideally include rigorous training and qualification criteria for practitioners, akin to the well-defined protocols followed in countries like South Korea, which has successfully integrated thyroid ablation into their healthcare system.

How to find a thyroid ablation doctor?

For patients considering thyroid ablation, finding a qualified and experienced practitioner is crucial. Dr. Dhingra suggests visiting www.rfamd.com, a resource that can help patients connect with skilled ablation doctors. This platform provides an avenue for patients to seek treatment from professionals who are not only proficient in ultrasound-guided procedures but also have a thorough understanding of when ablation is appropriate.

The rapid adoption of thyroid ablation in the United States represents a double-edged sword; it’s a promising treatment that can significantly benefit patients when applied judiciously and with the proper expertise. However, without careful consideration of the risks and strict adherence to guidelines, its potential benefits could be overshadowed by adverse outcomes. As the medical community continues to embrace this innovative treatment, the emphasis must remain on patient safety, thorough practitioner training, and the judicious application of thyroid ablation.

FIND MORE INFO ABOUT THYROID ABLATION, CLICK HERE

 

🔷🔷🔷🔷

About Philip James

As the host of the popular RFAMD and Doctor Thyroid podcasts, Philip James remains committed to sharing inspiring stories, valuable insights, and groundbreaking discoveries in the world of healthcare, making a positive impact on the lives of countless listeners.

Philip’s thought-provoking interviews have covered a wide range of healthcare topics, from cutting-edge technologies and surgical advancements to patient experiences and the impact of medical research on society.

• LinkedIn

About RFAMD

RFAMD is solely dedicated to helping healthcare organizations build deeper, enduring relationships with patients. Our team brings together expertise and insights to create enterprise-wide solutions that transform the patient experience. With years of experience in understanding the patient’s journey, we can help healthcare organizations thrive in today’s patient-centered healthcare market. Our range of solutions includes smart, measurable patient acquisition programs, physician marketing touch-points that drive referrals into priority service lines, and credible, easy-to-digest content at the point of care and beyond, in patients’ preferred formats and languages. We also provide brand strategies that increase patient preference and physician referrals and differentiate your brand in the market through reputation-building tools. Our commitment is to enable providers and payers to deliver personalized care by activating, educating, and motivating patients to prioritize their health every day. As your strategic partner, we combine our unique capabilities and industry expertise to better engage patients at every step of their health journey. Our goal is to help healthcare organizations achieve stronger patient and member outcomes, sustained improvements in brand reputation, measurable gains in market share, and increased revenue.

www.rfamd.com

In an enlightening episode of the RFAMD podcast, hosted by Philip James, Dr. Emad Kandil from Tulane University casts a new light on the treatment of thyroid conditions, challenging conventional surgical approaches and advocating for the pioneering method of thyroid ablation. This interview not only delves into Dr. Kandil’s personal journey into medicine but also explores the evolving landscape of thyroid treatment, highlighting the potential benefits of ablation over traditional surgery.

Personal Journey to Medicine

The episode begins with a personal anecdote from Dr. Kandil, tracing his initial passion for mathematics and critical thinking to a pivotal moment in his youth involving his brother’s seizure. This incident, occurring in his native Egypt, steered him away from engineering towards a career in medicine, driven by a newfound desire to make a tangible impact on people’s lives.

Thyroid Ablation: A Minimally Invasive Alternative

With thousands of thyroid surgeries under his belt, Dr. Kandil is not your typical advocate against surgery. However, his pioneering work in thyroid ablation in the United States, with nearly a thousand procedures to his credit, positions him uniquely in this field. Thyroid ablation, he explains, is increasingly being used to treat a variety of thyroid conditions, ranging from benign nodules to certain thyroid cancers, offering a less invasive option with fewer complications and a lesser impact on patients’ quality of life.

Challenges in Adopting New Medical Techniques

The conversation takes a critical turn as Dr. Kandil addresses the challenges in the widespread adoption of thyroid ablation. He emphasizes the need for proper training and expertise among physicians to prevent complications. His concerns extend to the rapid expansion of training programs, warning against unqualified practitioners who might cause more harm than good.

Patient-Centric Approach and Recovery

Dr. Kandil also sheds light on the patient experience during and after thyroid ablation. He notes that most procedures are performed under local anesthesia, with some patients preferring sedation. The recovery is notably swift, with many patients able to leave the same day, which is a significant advantage over traditional surgery.

Navigating the Healthcare System

A significant portion of the interview is dedicated to discussing the cost of thyroid ablation in the United States and the challenges patients face due to the lack of insurance coverage for this new procedure. Dr. Kandil stresses the importance of patient education and advocacy, urging patients to thoroughly research their options and seek second opinions.

Looking Towards the Future

In his concluding remarks, Dr. Kandil reflects on the future of thyroid treatment. He envisions a shift towards fewer surgeries, enhanced by advancing technologies and precision techniques. His message is clear: the medical community must adapt to new, less invasive methods that prioritize patient well-being and quality of life. Dr. Emad Kandil’s interview with Philip James marks a significant step in bringing attention to thyroid ablation as a viable alternative to surgery. His insights and personal journey serve as a beacon for both medical professionals and patients navigating the complex world of thyroid treatment. As this method gains traction, it promises to reshape the landscape of thyroid care, prioritizing minimally invasive procedures that offer better outcomes and improved quality of life for patients.

Are you an ablation doctor or searching for one?

Get listed on the directory at www.rfamd.com ✅

 

🔷🔷🔷🔷

About Philip James

As the host of the popular RFAMD and Doctor Thyroid podcasts, Philip James remains committed to sharing inspiring stories, valuable insights, and groundbreaking discoveries in the world of healthcare, making a positive impact on the lives of countless listeners.

Philip’s thought-provoking interviews have covered a wide range of healthcare topics, from cutting-edge technologies and surgical advancements to patient experiences and the impact of medical research on society.

• LinkedIn

About RFAMD

RFAMD is solely dedicated to helping healthcare organizations build deeper, enduring relationships with patients. Our team brings together expertise and insights to create enterprise-wide solutions that transform the patient experience. With years of experience in understanding the patient’s journey, we can help healthcare organizations thrive in today’s patient-centered healthcare market. Our range of solutions includes smart, measurable patient acquisition programs, physician marketing touch-points that drive referrals into priority service lines, and credible, easy-to-digest content at the point of care and beyond, in patients’ preferred formats and languages. We also provide brand strategies that increase patient preference and physician referrals and differentiate your brand in the market through reputation-building tools. Our commitment is to enable providers and payers to deliver personalized care by activating, educating, and motivating patients to prioritize their health every day. As your strategic partner, we combine our unique capabilities and industry expertise to better engage patients at every step of their health journey. Our goal is to help healthcare organizations achieve stronger patient and member outcomes, sustained improvements in brand reputation, measurable gains in market share, and increased revenue.

www.rfamd.com

Pioneering the Future of Thyroid Care: A Conversation with Dr. Julia Noel

Palo Alto, CA — In a recent episode of the RFAMD podcast, host Philip James welcomed a trailblazer in the field of thyroid treatment, Dr. Julia Noel of Stanford University School of Medicine. Known for her pioneering work in thyroid ablation, Dr. Noel shared insights on the evolving landscape of thyroid care, emphasizing innovative ablation technologies that are reshaping patient experiences.

From Mathematics to Medicine

Dr. Noel’s journey into the medical field was not typical. Initially drawn to mathematics, inspired by her father, she found her calling in surgery, where she could blend problem-solving skills with a hands-on approach. This unique blend of analytical thinking and surgical precision has defined her career.

Ablation Over Surgery: A Paradigm Shift

Central to Dr. Noel’s practice is thyroid ablation, a technique that offers an alternative to traditional surgery. With over thousands of surgeries to her credit, she has been a vocal advocate for techniques like radiofrequency, ethanol, and microwave ablation. These methods, she notes, are crucial in reducing the need for invasive procedures, preserving thyroid function, and improving quality of life.

The Technology at the Forefront

During the interview, Dr. Noel highlighted the rapid advancement in ablation technology. She pointed out that while radiofrequency ablation is currently the most user-friendly and researched method, emerging technologies promise even more groundbreaking developments. These future techniques may not even rely on heat generation, opening new avenues for treatment.

Navigating the Risks

With any medical procedure come risks, and thyroid ablation is no exception. Dr. Noel candidly discussed potential complications like voice changes, discomfort, and nodal rupture. However, she reassured that most of these risks are minor and reversible, underlining the importance of skilled execution and patient awareness.

A Surge in Patient Education

An interesting aspect of Dr. Noel’s work is her approach to patient education and outreach, particularly through social media. She stressed the importance of accurate, high-quality information in guiding both patients and physicians, acknowledging the growing role of digital platforms in patient advocacy.

Challenges in Training and Standardization

As thyroid ablation gains popularity, Dr. Noel emphasized the need for standardized training and guidelines. She expressed concern over the “Wild Wild West” atmosphere as more doctors seek to learn these techniques, underscoring the need for cautious and well-guided adoption of the technology.

The Cost Factor

Addressing the practical aspects of thyroid ablation, Dr. Noel spoke about the variability in insurance coverage and costs in the United States. She noted that while some patients on the West Coast enjoy substantial coverage, others face significant out-of-pocket expenses, highlighting the need for broader insurance acceptance.

Looking to the Future

Dr. Noel’s vision for the future of thyroid treatment is one of optimism, contingent on the acceptance of new medical codes and continued technological innovation. She sees a world where thyroid nodules and cancer are treated more efficiently and less invasively, a testament to the dynamic nature of medical progress.

Dr. Julia Noel’s interview on the RFAMD podcast provides a compelling look into the future of thyroid care. Her dedication to advancing treatment options, patient education, and the safe adoption of new technologies sets a benchmark in the field of thyroid health. As these technologies evolve, Dr. Noel’s insights offer a valuable perspective on the potential for improved patient care and the importance of informed medical choices.

Are you an ablation doctor or searching for one?

Get listed on the directory at www.rfamd.com ✅

 

🔷🔷🔷🔷

About Philip James

As the host of the popular RFAMD and Doctor Thyroid podcasts, Philip James remains committed to sharing inspiring stories, valuable insights, and groundbreaking discoveries in the world of healthcare, making a positive impact on the lives of countless listeners.

Philip’s thought-provoking interviews have covered a wide range of healthcare topics, from cutting-edge technologies and surgical advancements to patient experiences and the impact of medical research on society.

• LinkedIn

Thyroid Ablation: A Game-Changer in Preserving Quality of Life

www.docthyroid.com

Thyroid disorders, particularly those requiring surgery, have long been a concern for patients due to the potential lifelong dependence on medication and associated quality of life changes. However, a significant shift is occurring in thyroid treatment with the advent of thyroid ablation, a technique that is rapidly gaining preference among patients and physicians alike.

The Rise of Thyroid Ablation

In a recent podcast interview on RFAMD, Dr. Erivelto Volpi, a renowned head and neck surgeon from São Paulo, Brazil, shared his extensive experience in thyroid ablation. Dr. Volpi, who has performed around 8,000 thyroid surgeries and 400 thyroid ablations in over 35 years, notes the growing trend towards thyroid ablation. He attributes this shift primarily to the preservation of the patient’s quality of life, a crucial factor often overshadowed in traditional surgical approaches.

Why Patients Prefer Thyroid Ablation

Dr. Volpi explains that most patients seeking thyroid ablation do so not just to avoid surgery but to maintain their quality of life. They fear the changes that lifelong medication post-surgery might bring, having seen friends or family struggle with hormone replacements. Thyroid ablation, which involves radiofrequency or microwave treatment, offers an effective alternative. It shrinks benign thyroid nodules and even treats initial cancers, preserving thyroid function and thus the patient’s pre-existing quality of life.

The Global Perspective and Acceptance

Thyroid ablation is not just a localized phenomenon. Dr. Volpi highlights its rapid adoption worldwide, with countries like South Korea, Brazil, Italy, France, Spain, Turkey, and Egypt leading in this practice. This global acceptance is partly due to patient advocacy and the internet, which have empowered patients to seek the best treatment options, often traveling across borders to access this care.

The Procedure and Its Benefits

Compared to conventional surgery, thyroid ablation is minimally invasive, with fewer complications like voice changes. Recovery is swift, often within 24 to 48 hours, significantly quicker than traditional surgery. This aspect further reinforces its preference among patients.

Are you an ablation doctor or searching for one?

Get listed on the directory at www.rfamd.com ✅

 

🔷🔷🔷🔷

About Philip James

As the host of the popular RFAMD and Doctor Thyroid podcasts, Philip James remains committed to sharing inspiring stories, valuable insights, and groundbreaking discoveries in the world of healthcare, making a positive impact on the lives of countless listeners.

Philip’s thought-provoking interviews have covered a wide range of healthcare topics, from cutting-edge technologies and surgical advancements to patient experiences and the impact of medical research on society.

• LinkedIn

FIND A THYROID ABLATION DOCTOR at www.rfamd.com FOLLOW @DoctorThyroid #thyroid #thyroidcancer #ultrasound

Introduction ⦿ Host: Welcome by the host of the RFAMD podcast. ⦿ Guest: Introduction of Dr. Giovanni Mauri, a medical professional from Milan, Italy.

Dr. Mauri's Journey into Medicine ⦿ Childhood Influence: Inspired by his father, a radiologist. ⦿ Career Choice: Fascination with radiology and interventional radiology. ⦿ Family Background: His father worked in diagnostic radiology in an oncological hospital.

History of Ablation in Italy ⦿ Early Adoption: Discussion of pioneers in ablation treatments in Italy, starting in the 1980s. ⦿ Development: The evolution of ablation techniques, from ethanol ablation for liver cancers to radiofrequency ablation.

Dr. Mauri's Specialization ⦿ Scope of Ablation: Treating various cancers (liver, kidney, lung, bone, soft tissues) with thermal ablation. ⦿ Focus on Thyroid Ablation: Special emphasis on treating both benign and malignant thyroid diseases.

Patient Success Stories ⦿ Personal Case: A female patient treated multiple times for lymph node metastasis, avoiding further surgery. ⦿ Impact on Patients: Emphasizing the success and life-changing effects of successful thyroid ablation treatments.

Thyroid Surgery vs. Ablation ⦿ Patient Perspective: Benefits in terms of invasiveness and future hormonal treatment. ⦿ Medical Community: Surgeons appreciating the option of ablation to manage resources and time effectively.

Global Trends in Thyroid Ablation ⦿ FDA Approval: The significant impact of FDA approval in the U.S. in 2018. ⦿ Rapid Growth: Thyroid ablation as the fastest-growing field in ablation treatments worldwide.

Dangers of Rapid Growth ⦿ Training and Expertise: Emphasizing the necessity of proper training and the risks posed by inexperienced practitioners. ⦿ Comparison of Techniques: Differences between traditional surgery and ultrasound-guided ablation procedures.

Pioneers in Thyroid Ablation ⦿ Innovations: Introduction of specifically designed needles and techniques in Korea and Italy. ⦿ Global Adoption: The spread of thyroid ablation practices to countries like South America, North America, and Europe.

Risks of Thyroid Ablation ⦿ Medical Risks: Potential damages during the procedure, such as bleeding or nerve damage. ⦿ Technical Challenges: Importance of ultrasound skills and adjunctive techniques to minimize risks.

Post-Treatment Recovery ⦿ Patient Experience: Comparing recovery to dental work, with minimal pain and quick return to normal life. ⦿ Potential Complications: Rare cases of hematoma, mainly aesthetic concerns.

Unsuccessful Cases ⦿ Benign Nodules: Rare unsuccessful cases, often due to initial under-treatment. ⦿ Malignant Tumors: Possibility of incomplete ablation, with options for re-treatment.

Selecting the Right Provider ⦿ Criteria for Choosing: Experience of the physician, ideally in a hospital setting for beginners. ⦿ Importance of Supervision: Emphasis on proper environment and supervision for new practitioners.

Addressing Skepticism ⦿ Literature and Communication: Using scientific evidence and open discussions to address concerns. ⦿ Surgical Alternatives: Emphasizing ablation as a reversible option compared to definitive surgery.

Types of Ablation ⦿ Radiofrequency vs. Microwave: Discussion on the advantages and risks of each type in thyroid treatments.

Guidelines and Clinical Experience ⦿ Lag in Guidelines: The delay in incorporating new treatments like ablation into official guidelines. ⦿ Individualized Treatment: Tailoring treatment options based on clinical experience, despite guidelines.

Patient Counseling ⦿ Approach to Counseling: The importance of discussing all treatment options with patients. ⦿ Team Collaboration: Multidisciplinary approach in decision-making and patient communication.

Patient Perception and Decision Making ⦿ Overdiagnosis and Overtreatment: Addressing the issue of overdiagnosis in thyroid cancer and the role of minimally invasive treatments. ⦿ Patient Preferences: Understanding patient choices in treatment options, including active surveillance.

Second Opinions and Treatment Choices ⦿ Changing Treatment Plans: Cases where patients change their mind after seeking a second opinion. ⦿ Informed Decision Making: The importance of providing comprehensive information to patients.

Innovations in Thyroid Treatment ⦿ New Technologies: Exploring new treatments like embolization, expanding the scope of minimally invasive procedures.

Conclusion and Rapid Fire Questions ⦿ Future of Thyroid Treatment: Predictions about the shift towards ablation in the next decade. ⦿ Importance of Communication: The crucial role of clear communication in discussing cancer treatments with patients.

For podcast inquiries or if you would like to be a guest. Contact: [email protected]

In a podcast episode featuring Dr. Vaninder Dhillon from Johns Hopkins and hosted by Philip James, the discussion centers on the prevalence, detection, and treatment of thyroid nodules, focusing on ablation therapy as an alternative to surgery.

Dr. Dhillon, an assistant professor in the Department of Otolaryngology at Johns Hopkins, specializes in the surgical management of thyroid and parathyroid diseases. She explains that thyroid nodules are quite common in the American population, with an estimated 30 to 50% of people having at least one thyroid nodule, the majority of which are benign. These nodules are often discovered incidentally through advanced imaging technologies or during physical examinations when patients experience symptoms like lumps or pressure in the neck.

The conversation shifts to the treatment of multiple thyroid nodules. Dr. Dhillon points out that while it's not uncommon to have multiple nodules, the treatment approach has evolved. Previously, surgery was the standard treatment, but now, ablation is considered a viable, less invasive option that can preserve the rest of the functioning thyroid gland.

Ablation is particularly effective for patients with multiple benign nodules, especially when the thyroid gland itself is not enlarged. It provides targeted volume reduction of the nodules, aiming to alleviate symptoms such as difficulty swallowing, voice changes, or neck discomfort. However, for patients with an enlarged thyroid gland, surgery might still be necessary if the gland size rather than the nodules is causing symptoms.

Dr. Dhillon also touches on treating malignant nodules, stating that while surgery remains the primary treatment for thyroid cancers in the U.S., ablation can be considered for patients who are not candidates for surgery or have recurrent disease.

The podcast emphasizes a new paradigm in thyroid nodule treatment: surgery is not always necessary, and in many cases, ablation can be an effective treatment. This is particularly significant for patients who wish to avoid surgery and its potential complications, such as the need for lifelong thyroid medication.

Dr. Dhillon encourages those with multiple thyroid nodules to seek expert consultation about ablation, as it could be a suitable treatment option. The episode concludes with a reminder that treatment approaches are changing, and patients have options beyond surgery, reinforcing the importance of discussing these with a healthcare provider specialized in this field. Dr. Dhillon's contact information is provided for those interested in further discussion or treatment.

Treating Thyroid Nodules Without Surgery: An Insightful Discussion with Dr. Vaninder Dhillon

Find more info about thyroid ablation at: www.rfamd.com

The thyroid gland, a butterfly-shaped organ in the neck, is known to develop nodules or growths. While these nodules are often benign, they can sometimes cause cosmetic concerns or other symptoms for patients. Traditionally, surgical removal was the primary solution. But a revolutionary alternative, thyroid ablation, offers a less invasive approach, preserving both the thyroid gland and its functions.

In a recent episode of the Doctor Thyroid podcast, Philip James interviewed Dr. Vaninder Dhillon, a reputed professional from Johns Hopkins, to delve deep into thyroid ablation and what patients can expect post-treatment.

A Non-Surgical Solution: Thyroid Ablation

Thyroid ablation is a minimally invasive treatment targeting the thyroid nodule directly. The most common type of ablation used is radiofrequency ablation, which employs a specific type of energy to address the nodule without affecting the rest of the thyroid gland.

Unlike surgeries where parts of the gland might need to be removed, causing hormonal disruptions, ablation offers the benefit of not depriving patients of their thyroid or its hormones.

The Journey of Nodule Reduction

Dr. Dhillon explained that while the treatment does not make the nodule vanish instantly, the goal is to reduce its size and volume significantly. Using radiofrequency ablation, patients can expect a volume reduction of 60 to 80 percent within six months of the treatment, especially for nodules less than 20 milliliters cubed in size.

However, it’s crucial to note that the timeline and effectiveness may vary based on the nodule’s initial size and location. Anatomical considerations also play a vital role in the treatment process.

Addressing Both Benign and Malignant Nodules

While the guidelines discussed focus primarily on benign nodules, the treatment is also a consideration for malignant nodules, especially if the patient has recurrent disease or is at high risk for another surgery.

The Follow-up

Post-ablation, patients typically return to Dr. Dhillon’s office at intervals of one month, three months, six months, and a year. These follow-ups ensure that the volume of the nodule is reducing and that the thyroid hormone levels remain stable.

Rapid-Fire Takeaways

Dr. Dhillon stressed the importance of patients understanding that the primary goal of ablation is to reduce the size of the nodule over the long term. The treatment provides an excellent alternative for patients, offering them the opportunity to direct treatment to specific nodules without the risks or uncertainties linked with surgical procedures.

Concluding Remarks

The discussion with Dr. Dhillon offers a beacon of hope to countless patients grappling with thyroid nodules, giving them insight into a less invasive solution that puts their well-being first. As medical innovations like thyroid ablation become more mainstream, patients have more choices, ensuring they receive the best care tailored to their unique needs.

For more details about Dr. Dhillon and her contributions to the thyroid community, including her presentations at the American Thyroid Association conference, readers can refer to the links provided in the podcast episode description.

 

🔷🔷🔷🔷

About Dr. Vaninder Dhillon

Assistant Professor of Otolaryngology – Head and Neck Surgery

Vaninder “Vinny” K. Dhillon, M.D., is an assistant professor of otolaryngology – head and neck surgery at Johns Hopkins University School of Medicine, specializing in both children and adults. She practices out of Johns Hopkins Otolaryngology – Head and Neck Surgery in Bethesda, Maryland. Dr. Dhillon is also affiliated with Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore, Maryland, as well as Sibley Memorial Hospital in Washington, D.C.

Dr. Dhillon has an expertise in endocrine surgery, laryngology, otolaryngology, parathyroid diseases and surgery, swallowing disorders, thyroid diseases and surgery, and voice problems.

Dr. Dhillon earned her medical degree from Keck School of Medicine of University of Southern California. She completed a residency in otolaryngology at Los Angeles County and University of Southern California Medical Center.

View Full Profile: https://www.rfamd.com/vaninder-dhillon/

About Philip James

As the host of the popular RFAMD and Doctor Thyroid podcasts, Philip James remains committed to sharing inspiring stories, valuable insights, and groundbreaking discoveries in the world of healthcare, making a positive impact on the lives of countless listeners.

Philip’s thought-provoking interviews have covered a wide range of healthcare topics, from cutting-edge technologies and surgical advancements to patient experiences and the impact of medical research on society.

• LinkedIn

About RFAMD

RFAMD is solely dedicated to helping healthcare organizations build deeper, enduring relationships with patients. Our team brings together expertise and insights to create enterprise-wide solutions that transform the patient experience. With years of experience in understanding the patient’s journey, we can help healthcare organizations thrive in today’s patient-centered healthcare market. Our range of solutions includes smart, measurable patient acquisition programs, physician marketing touch-points that drive referrals into priority service lines, and credible, easy-to-digest content at the point of care and beyond, in patients’ preferred formats and languages. We also provide brand strategies that increase patient preference and physician referrals and differentiate your brand in the market through reputation-building tools. Our commitment is to enable providers and payers to deliver personalized care by activating, educating, and motivating patients to prioritize their health every day. As your strategic partner, we combine our unique capabilities and industry expertise to better engage patients at every step of their health journey. Our goal is to help healthcare organizations achieve stronger patient and member outcomes, sustained improvements in brand reputation, measurable gains in market share, and increased revenue.

www.rfamd.com

  Content on the RFAMD and Doctor Thyroid with Philip James websites and podcasts is for informational purposes only and not a substitute for professional medical advice. See our full Legal Disclaimer for details.

En la reciente conferencia TNT en Reggio Emilia 2023: 2da Reunión Internacional sobre Terapias Mínimamente Invasivas Guiadas por Ultrasonido, el anfitrión del podcast Doctor Thyroid y RFAMD, Philip James, tuvo la oportunidad de entrevistar a la Dra. Lorena Savluk, una destacada radióloga intervencionista de Buenos Aires, Argentina.

La Dra. Savluk fue bienvenida por James, agradeciendo su presencia y su disposición para hablar sobre el impacto de las terapias mínimamente invasivas en el tratamiento de los nódulos tiroideos y el cáncer de tiroides. "En esta conferencia, estamos discutiendo tratamientos de nódulos tiroideos a través de la ablación por radiofrecuencia y por microondas, aunque el enfoque principal es la radiofrecuencia", explicó la Dra. Savluk.

La terapia de ablación por radiofrecuencia surge como una alternativa a la cirugía, para el tratamiento tanto de nódulos benignos como de microcarcinomas o cáncer de tiroides recurrente en el cuello. Esta terapia minimiza la necesidad de intervenciones quirúrgicas permitiendo a los pacientes mantener la glándula y su función.

En este sentido, la Dra. Savluk destacó que "esta terapia es particularmente útil para los pacientes con microcarcinoma papilar de tiroides que no desean someterse a una operación, o que prefieren no estar en un régimen de seguimiento activo". Además, es especialmente efectiva para el cáncer de tiroides recurrente en los ganglios del cuello.

James preguntó sobre la disponibilidad de esta terapia en Argentina, a lo que la Dra. Savluk confirmó su presencia en el país. "Nuestro equipo ha estado realizando estas terapias desde 2021. Hemos tratado a un número considerable de pacientes con resultados muy prometedores. Los pacientes están satisfechos, principalmente porque no tienen que pasar por el quirófano", afirmó.

La costumbre de este procedimiento en Argentina ronda los 2,000 dólares, y para los pacientes interesados en obtener más información, la Dra. Savluk recomendó visitar la página de rfa. Allí se puede encontrar un directorio de todos los médicos que ofrecen este tratamiento, facilitando la búsqueda de un profesional en su región o área de interés.

La entrevista concluyó con saludos desde Italia y promesas de futuras discusiones sobre el tema. Con terapias mínimamente invasivas como la ablación por radiofrecuencia en aumento, las opciones de tratamiento para los nódulos y el cáncer de tiroides están evolucionando rápidamente, brindando a los pacientes alternativas más amigables y menos invasivas.

Molecular Profiling of Thyroid Nodules: A Conversation with Dr. Steven Hodak

In a recent podcast episode of Doctor Thyroid and RFAMD, host Philip James was joined by Dr. Steven Hodak, a Professor of Medicine and Endocrinology at NYU Langone Health, New York. Dr. Hodak, who is also the President of the North American Society for Interventional Fibrinology, was present at the TNT conference in Italy when the podcast was recorded. The pair dived into the intriguing topic of molecular profiling of thyroid nodules and how it could relate to either ablation or thyroidectomy.

The Significance of Molecular Diagnostic Testing

Dr. Hodak began by explaining the relevance of molecular diagnostic testing to thyroid nodule ablation. He recounted that, ten to fifteen years ago, before molecular diagnostic testing was widely available, patients with an indeterminate nodule biopsy would almost always undergo surgery for a definitive diagnosis. This was due to the nodule not appearing normal, yet not definitively looking like cancer either. As a result, the only solution at the time was to remove the nodule, examine it under the microscope, and then provide a definite diagnosis.

The shocking part of this approach was that in 80% of cases, patients did not have cancer, and would never have developed it. That meant these patients underwent a surgery that could have been avoided had the molecular diagnostic testing been available. Today, however, this testing has been revolutionary, enabling preoperative risk stratification of nodules, potentially avoiding unnecessary surgical interventions.

Concerns Over Previous Practice

Host Philip James highlighted the alarming nature of the previous practice where 80% of patients with an indeterminate thyroid nodule would undergo surgery as a diagnostic step. The patients would have their thyroid removed, only to discover that they did not have cancer.

Dr. Hodak acknowledged the concern, explaining that while it may sound like an uncaring and unnecessary approach, the limitations of diagnostic methods available at the time left no other choice. Leaving the nodule there to 'see what happens' could have led to worse consequences if it was indeed cancerous.

The Present Scenario and Global Adoption

Currently, Dr. Hodak confirmed that molecular diagnostics is widely used by most doctors in the United States, thanks to the availability of good commercially available tests. However, he admitted that outside the U.S., it is still a struggle, primarily due to the lack of willingness among socialized medical programs to cover the cost.

Dr. Hodak emphasized that the adoption of molecular diagnostics testing worldwide is crucial. He acknowledged that the U.S. had its struggles too before it was widely accepted, often due to inertia and resistance to change. However, the cost-saving potential of molecular diagnostics, along with the ability to reassure patients of a low risk in 60 to 70% of cases, underlines its potential.

Molecular Testing and Ablation

Dr. Hodak also discussed the connection between molecular testing and ablation. He noted that some of the questions regarding molecular testing and ablation remain open. For tumors with a negative genetic profile, which essentially equates to having a benign microscopic diagnosis, ablation can be used as a treatment method. For those with a positive genetic finding, however, the decision to offer ablation instead of surgery is still under active study.

Dr. Hodak affirmed the growing personalization of care, thanks to technology advancements such as molecular testing, AI imaging, and ablation.

Concluding Remarks

In conclusion, Dr. Hodak stressed the importance of incorporating molecular profiling in decision-making regarding thyroid nodule treatment. For countries where this technology is readily available, it should be part of the treatment planning. For those where it is not, it remains an unfortunate reality and a sore point

🔷🔷🔷🔷The Doctor Thyroid and RFAMD podcast with Philip James is listened to in 100+ countries. It is a preferred patient resource for information related to thyroid cancer, RFA, hypothyroidism, pathology, and radiation therapy.

Contact Philip [email protected]

www.rfamd.com www.docthyroid.com

About Philip James

He is the host of the popular podcast: Doctor Thyroidwww.docthyroid.com

In 2013, his laryngeal nerve was severed, shoulder nerve damaged, parathyroids ruined, and residual cancer left behind — all for a 1 cm thyroid nodule.Later, a vocal cord implant was inserted to help him speak.

100+ episodes later, the Doctor Thyroid podcast is popular amongst patients; allowing them to access information from top doctors, without being limited by geography or economics.

The word he uses to describe his work as patient advocate is, ‘tonglen’. Or, using his pain and hardship to help others.

The Doctor Thyroid podcast is available in Spanish and English – and listened to in over 30 countries:

www.doctiroides.com (Spanish)

www.docthyroid.com (English)

Please email your requests to [email protected]

Instagram: @PhilipJames360

LinkedIn:  www.linkedin.com/in/philip-james/

Facebook: @philipb07

YouTube: @Doctor Thyroid Twitter : @docthyroid

 

In a recent episode of the Doctor Thyroid and RFAMD podcasts, Dr. Vaninder Dhillon, an esteemed laryngologist and ENT surgeon from Johns Hopkins, highlighted the critical issue of voice and swallow risks associated with thyroidectomy and thyroid ablation.

#thyroid #thyroidcancer #thyroidsurgery SUBSCRIBE @DoctorThyroid AVOID SURGERY www.rfamd.com@JohnsHopkinsMedicine 

The interview sheds light on the importance of preserving the voice and offered insights into innovative approaches to avoid surgery.

Dr. Dhillon, who has extensive experience in both laryngology and endocrine head and neck surgery, underscored the significance of the voice and swallow outcomes in patients undergoing these procedures. Her research and clinical practice focus on improving outcomes and quality of life for patients who may face post-operative issues with their voice and swallow, as well as those with general voice and swallow complaints.

One of the most common complications after thyroid surgery is vocal cord paralysis, which can have a significant impact on a patient's voice. While the overall percentage of patients experiencing voice issues after thyroidectomy varies, it can be as high as 30 to 50 percent, with temporary paralysis affecting up to 15 percent. Although permanent paralysis is rarer (1-2 percent), it remains a concern for patients.

During the interview, Dr. Dhillon emphasized the importance of differentiating between voice and swallowing outcomes, as the latter is often overlooked. Swallowing complaints are higher than voice complaints, with some studies showing up to 60 percent of patients experiencing temporary swallowing issues post-operatively.

Voice and swallow assessments are crucial before and after surgery. Dr. Dhillon stressed the need for a comprehensive evaluation, including endoscopy and video stroboscopy, to examine the larynx more closely during speech. These assessments help in identifying potential issues with the recurrent laryngeal nerve and the superior laryngeal nerve.

Dr. Dhillon's team has implemented voice and swallow tests before surgery, and they continue to monitor patients post-operatively to ensure any issues are addressed promptly. This proactive approach helps patients feel more confident and informed about the potential risks to their voice and swallow function.

The conversation also discussed the rise of radiofrequency ablation (RFA) as an alternative to surgery. RFA is a minimally invasive technology for treating thyroid nodules and thyroid cancers. While RFA has a lower risk of voice and swallow complications than surgery, Dr. Dhillon stressed the importance of a thorough pre-RFA laryngeal exam to ensure optimal outcomes.

However, Dr. Dhillon acknowledged that more research is needed to fully understand the potential voice and swallow risks associated with RFA. Standardized protocols and patient-reported outcomes can be vital in evaluating these risks and ensuring patient safety during the procedure.

Dr. Vaninder Dhillon highlighted the importance of safeguarding the voice and swallow function in thyroid surgery and ablation. By proactively evaluating and addressing potential complications, patients can make informed decisions and seek appropriate interventions to protect their vocal and swallowing abilities. The ongoing research and innovative approaches in this field offer hope for improved outcomes and a better quality of life for those affected by thyroid conditions.

About Philip James  As the host of the popular RFAMD and Doctor Thyroid podcasts, Philip James remains committed to sharing inspiring stories, valuable insights, and groundbreaking discoveries in the world of healthcare, making a positive impact on the lives of countless listeners.

Philip's thought-provoking interviews have covered a wide range of healthcare topics, from cutting-edge technologies and surgical advancements to patient experiences and the impact of medical research on society.

About Dr. Dhillon Assistant Professor of Otolaryngology – Head and Neck Surgery

Vaninder “Vinny” K. Dhillon, M.D., is an assistant professor of otolaryngology – head and neck surgery at Johns Hopkins University School of Medicine, specializing in both children and adults. She practices out of Johns Hopkins Otolaryngology – Head and Neck Surgery in Bethesda, Maryland. Dr. Dhillon is also affiliated with Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore, Maryland, as well as Sibley Memorial Hospital in Washington, D.C.

Dr. Dhillon has an expertise in endocrine surgery, laryngology, otolaryngology, parathyroid diseases and surgery, swallowing disorders, thyroid diseases and surgery, and voice problems.

Dr. Dhillon earned her medical degree from Keck School of Medicine of University of Southern California. She completed a residency in otolaryngology at Los Angeles County and University of Southern California Medical Center.

IG: vaninderdhillonmd Twitter: @VaninderD